Moderna, Inc. (NASDAQ:MRNA) | WebDisclosure

Basculer en Français

10832	Companies
235110	Keywords
164015	Articles
125897	Press releases

Home
Companies
Moderna, Inc.

PRESS RELEASE

published on 09/17/2024 at 17:00, 1 year 10 months ago

Moderna Receives Health Canada Approval For Updated COVID-19 Vaccine Targeting KP.2 Variant Of SARS-COV-2 For Ages Six Months And Older
Moderna's SPIKEVAX® KP.2 variant COVID-19 vaccine authorized in Canada for 2024-2025 season to protect against COVID-19 strains. Delivery to begin promptly for vaccination campaigns

COVID-19 Vaccine Health Canada Moderna Spikevax Vaccination Campaigns
PRESS RELEASE

published on 09/17/2024 at 17:00, 1 year 10 months ago

Moderna reçoit l'approbation de Santé Canada pour le vaccin COVID-19 mis à jour ciblant le variant KP.2 du SRAS-COV-2 pour les personnes âgées de six mois et plus
Moderna Inc. obtient l'autorisation de Santé Canada pour son vaccin SPIKEVAX® mis à jour contre la COVID-19 pour le variant KP.2, renforçant la protection pendant les saisons automne-hiver 2024-2025

COVID-19 Moderna Inc. Santé Canada Vaccin SPIKEVAX®
BRIEF

published on 09/12/2024 at 12:05, 1 year 11 months ago

Moderna R&D Day Highlights Progress and Strategic Priorities

COVID-19 Vaccine Financial Outlook Vaccine Approvals Moderna Updates R&D Strategy
BRIEF

published on 09/12/2024 at 12:05, 1 year 11 months ago

La journée de recherche et développement de Moderna met en lumière les progrès et les priorités stratégiques

Perspectives Financières Vaccin Contre Le Covid-19 Mises À Jour De Moderna Stratégie De R&D Approbations De Vaccins
PRESS RELEASE

published on 09/12/2024 at 12:00, 1 year 11 months ago

Moderna R&D Day Highlights Progress and Strategic Priorities
Moderna, Inc. announces program updates focusing on ten product approvals through 2027, submission of next-gen COVID vaccine and flu/COVID combo vaccine in 2024, positive Phase 3 results for RSV vaccine, and cost efficiency improvements

Moderna Vaccine Phase 3 Results Product Approvals R&D Expense Reduction
BRIEF

published on 09/09/2024 at 13:05, 1 year 11 months ago

Moderna’s Canadian Manufacturing Facility Receives Drug Establishment License From Health Canada

Health Canada Moderna MRNA Vaccines Laval Facility Drug Establishment License
BRIEF

published on 09/09/2024 at 13:05, 1 year 11 months ago

L'usine canadienne de Moderna obtient une licence d'établissement de médicaments de Santé Canada

Vaccins À ARNm Moderne Santé Canada Établissement De Laval Licence D'établissement De Produits Pharmaceutiques
PRESS RELEASE

published on 09/09/2024 at 13:00, 1 year 11 months ago

Moderna’s Canadian Manufacturing Facility Receives Drug Establishment License From Health Canada
Moderna's Laval facility in Canada attains Drug Establishment License, a key step towards onshore mRNA vaccine production by 2025. This milestone boosts national vaccine supply

Canada Manufacturing Facility Moderna MRNA Vaccines Drug Establishment License
BRIEF

published on 09/05/2024 at 14:05, 1 year 11 months ago

EMA Recommends Authorization of Moderna's Updated COVID-19 Vaccine Targeting SARS-CoV-2 Variant JN.1

Authorization COVID-19 Vaccine Moderna EMA SARS-CoV-2 Variant
BRIEF

published on 09/05/2024 at 14:05, 1 year 11 months ago

L'EMA recommande l'autorisation du vaccin COVID-19 mis à jour de Moderna ciblant la variante JN.1 du SARS-CoV-2

Moderne Vaccin Contre Le Covid-19 Autorisation EMA Variante Du SARS-CoV-2

Accesswire

Published on 08/14/2026 at 00:15, 54 minutes ago

Corporate Update - QCM Property Exploration Update
Published on 08/13/2026 at 22:38, 2 hours 31 minutes ago

Predictiv AI Announces Debt Settlement and Provides Additional Details of Previously Announced Consulting Agreement With Aktien Media Inc.
Published on 08/13/2026 at 19:55, 5 hours 14 minutes ago

NuRAN Wireless Receives Nasdaq Approval to List on The Nasdaq Capital Market; Trading Expected to Commence August 17, 2026 and C$7.6 Million Financing to Close August 14, 2026
Published on 08/13/2026 at 17:55, 7 hours 14 minutes ago

Alset AI Announces Agreement to Sell 9.9% Interest in Lyken AI Computing to FingerMotion
Published on 08/13/2026 at 14:31, 10 hours 38 minutes ago

Wi2Wi Announces Strategic Equipment Investments to Expand Production Capacity

View all ACCESSWIRE

EQS Group

Published on 08/13/2026 at 23:20, 1 hour 49 minutes ago

DeFi Technologies Inc. Announces Second Quarter 2026 Financial Results with Revenue of $7.8 Million, Operating Loss of $2.3 Million, and Maintained Strong Balance Sheet
Published on 08/13/2026 at 22:56, 2 hours 13 minutes ago

BIRKENSTOCK ANNOUNCES LAUNCH OF SECONDARY OFFERING AND CONCURRENT SHARE REPURCHASE
Published on 08/13/2026 at 18:17, 6 hours 52 minutes ago

EQS-Adhoc: Energiekontor AG: Energiekontor adjusts earnings guidance for the 2026 financial year
Published on 08/13/2026 at 18:00, 7 hours 9 minutes ago

Issue of Equity
Published on 08/13/2026 at 18:00, 7 hours 9 minutes ago

Deutsche EuroShop reports good operational performance in the first half of 2026 and confirms its forecast

Les Echos

Published on 08/13/2026 at 18:00, 7 hours 9 minutes ago

Chiffre d’affaires du 1er trimestre 2026-27 : 14,4 M€
Published on 08/11/2026 at 17:45, 2 days 7 hours ago

DAMARTEX / Droits de vote bruts et réels au 31 juillet 2026
Published on 08/11/2026 at 17:40, 2 days 7 hours ago

Infotel : Déclaration des transactions sur actions propres réalisées du 3 au 7 août 2026 dans le cadre du programme de rachat d’actions
Published on 08/10/2026 at 18:00, 3 days 7 hours ago

AXA: Information relating to the number of voting rights and shares making up the share capital on 31/07/2026
Published on 08/10/2026 at 18:00, 3 days 7 hours ago

AXA : Information relative au nombre total de droits de vote et d'actions composant le capital social au 31/07/2026

View all LES ECHOS COMFI WIRE